胃横截面积预测重症患者胃不耐受:Sono-ICU 前瞻性观察双中心研究
这项法国双中心前瞻性观察研究纳入 44 例接受肠内喂养超过 12 小时的外科插管 ICU 患者,其中 11 例(25%)出现消化道不耐受。发生上消化道不耐受者 GCSA 显著高于未发生者(553 mm² vs 970 mm²,p<0.001)。预测上消化道不耐受的最佳阈值为 720 mm²(AUC 0.86,阳性预测值 62.5%,阴性预测值 96.4%,敏感度 0.91,特异度 0.81)。多因素分析(倾向评分加权)显示 GCSA 超过 720 mm² 与上消化道不耐受独立相关(OR 1.85,95%CI 1.37-2.49,p<0.0002)。作者认为超声测量 GCSA 可预测重症患者胃不耐受,但需前瞻性评分验证和干预性试验确认。
要点
- 接受肠内喂养超过 12 小时的外科插管 ICU 患者中,上消化道不耐受者 GCSA 显著高于无不耐受者(553 mm² vs 970 mm²,p<0.001)。
- 预测上消化道不耐受的最佳 GCSA 阈值为 720 mm²(AUC 0.86,敏感度 0.91,特异度 0.81,阳性预测值 62.5%,阴性预测值 96.4%)。
- 多因素分析(倾向评分加权)显示 GCSA>720 mm² 与上消化道不耐受独立相关(OR 1.85,95%CI 1.37-2.49,p<0.0002)。
- 81% 的测量质量评为「好」,即肝、主动脉、肠系膜上静脉和胰腺均可见。
- 作者认为超声测量 GCSA 可预测重症患者胃不耐受,但需前瞻性评分验证和干预性试验确认。
适用人群与场景
- 法国两家学术 ICU 中,2020 年 6 月至 2021 年 8 月收治的≥18 岁、接受肠内喂养超过 12 小时的外科插管重症患者。
诊断标准与关键阈值
- 预测上消化道不耐受的最佳 GCSA 阈值为 720 mm²(AUC 0.86;阳性预测值 62.5%;阴性预测值 96.4%;敏感度 0.91;特异度 0.81)。
- GCSA 测量质量「好」定义为肝、主动脉、肠系膜上静脉和胰腺均可见。
研究设计与关键结果
- 双中心前瞻性观察研究,纳入 44 例外科插管 ICU 患者,11 例(25%)出现消化道不耐受。
- 上消化道不耐受患者 GCSA 显著高于无上消化道不耐受患者(553 mm² [IQR 500-649 mm²] vs 970 mm² [IQR 777-1,047 mm²],p<0.001)。
- 预测上消化道不耐受的最佳 GCSA 阈值为 720 mm²(AUC 0.86;阳性预测值 62.5%;阴性预测值 96.4%;敏感度 0.91;特异度 0.81)。
- 多因素分析(倾向评分加权)纳入已知危险因素后,GCSA 超过 720 mm² 与上消化道不耐受独立相关(OR 1.85,95%CI 1.37-2.49,p<0.0002)。
- 测量质量「好」(肝、主动脉、肠系膜上静脉和胰腺均可见)占 81%。
证据类型、等级与局限
- 证据类型:双中心前瞻性观察研究。
- 局限:作者指出该结果需前瞻性评分验证和干预性试验确认。
对床旁实践的改变
- 作者认为,通过超声测量 GCSA 可预测重症患者胃不耐受,但需前瞻性评分验证和干预性试验确认。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: To evaluate the correlation between gastric cross-sectional area (GCSA) and the occurrence of gastric intolerance in critically ill patients within 24 hours of the measurement.
DESIGN: Two-center prospective observational study.
SETTING: Two academic ICUs in France between June 2020 and August 2021.
PATIENTS: All surgical intubated ICU patients greater than or equal to 18 years old receiving enteral feeding for greater than 12 hours.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Forty-four patients were included, 11 (25%) of whom presented digestive intolerance. Primary outcome was assessment of the association between GCSA and the occurrence of gastric intolerance within 24 hours of the measurement. GCSA value was significantly higher in patients with upper digestive intolerance compared to those without (553 mm2 [interquartile range (IQR), 500-649 mm2] vs 970 mm2 [IQR, 777-1,047]; p < 0.001, respectively). The optimal threshold for predicting upper digestive intolerance was 720 mm2 (area under the receiver operating characteristic curve 0.86; positive predictive value 62.5%; negative predictive value 96.4%; sensibility 0.91; and specificity 0.81). Multivariate analysis (weighted by propensity score), including known risk factors, showed that GCSA above the 720 mm2 threshold was independently associated with the occurrence of upper digestive intolerance (odds ratio, 1.85; 1.37-2.49; p < 0.0002). Measurement quality was "good" (i.e., liver, aorta, superior mesenteric vein, and pancreas were all visualized) in 81% of cases.
CONCLUSIONS: Measurement of GCSA by ultrasound would allow prediction of gastric intolerance in critically ill patients. This should be confirmed by a prospective score validation and interventional trials.
参考来源
- El Khoury D, Pardo E, Cambriel A, et al. Gastric Cross-Sectional Area to Predict Gastric Intolerance in Critically Ill Patients: The Sono-ICU Prospective Observational Bicenter Study. Crit Care Explor. 2023. PMID: 36960310. doi:10.1097/CCE.0000000000000882
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。